![](\"http:\/\/www.erzurumflas.com\/wp-content\/uploads\/2020\/09\/bobrek-kanserinde-immunoterapilerin-onemi_06da966.jpg\")
D\u00fcnya \u00e7ap\u0131ndaki t\u00fcm yeni kanser vakalar\u0131n\u0131n y\u00fczde 2 ila 3 aras\u0131ndaki k\u0131sm\u0131n\u0131 olu\u015fturan ve g\u00f6r\u00fclme oran\u0131 y\u00fckselerek her y\u0131l binlerce insan\u0131n hayat\u0131n\u0131 kaybetmesine veya d\u00fc\u015f\u00fck ya\u015fam kalitesi ile hayat\u0131n\u0131 s\u00fcrd\u00fcrmesine neden olan b\u00f6brek kanserinin tedavisinde imm\u00fcnoterapiler ile farkl\u0131 tedavi kombinasyonlar\u0131 \u00f6nemli yer tutuyor.<\/p>\n
Bu y\u0131l 19-21 Eyl\u00fcl tarihleri aras\u0131nda, pandemi nedeniyle dijital ortamda d\u00fczenlenen ESMO 2020 Kongresi\u2019nde bir\u00e7ok kanser t\u00fcr\u00fc farkl\u0131 bak\u0131\u015f a\u00e7\u0131lar\u0131 ve yakla\u015f\u0131mlarla ele al\u0131nd\u0131. Kat\u0131l\u0131mc\u0131lar taraf\u0131ndan en ilgi g\u00f6ren konulardan biri de imm\u00fcno-onkoloji kombinasyon tedavisinin b\u00f6brek kanseri tedavisindeki rol\u00fcne ili\u015fkin veriler oldu.<\/p>\n
Ankara \u00dcniversitesi T\u0131bbi Onkoloji Bilim Dal\u0131 \u00d6\u011fretim \u00dcyesi Do\u00e7. Dr. Y\u00fcksel \u00dcr\u00fcn kongrede b\u00f6brek kanseri tedavisine y\u00f6nelik payla\u015f\u0131lan g\u00fcncel sonu\u00e7lar\u0131n heyecan verici oldu\u011funu dile getirdi.<\/p>\n
\u00dcr\u00fcn, kongrede \u00f6ne \u00e7\u0131kan bir bilimsel \u00e7al\u0131\u015fma da imm\u00fcnoterapi ve hedefe y\u00f6nelik bir ajan\u0131n birlikte kullan\u0131m\u0131n\u0131n b\u00f6brek kanserinin tedavisindeki rol\u00fcn\u00fc ortaya koydu. Imm\u00fcnoterapi ve hedefe y\u00f6nelik bir ajan\u0131n birlikte kullan\u0131m\u0131n\u0131n genel sa\u011fkal\u0131m ve t\u00fcm\u00f6r yan\u0131t\u0131nda olumlu sonu\u00e7lar ortaya koydu\u011fu a\u00e7\u0131kland\u0131. \u00dcr\u00fcn, toplam 651 hasta tedavisini kapsayan klinik Faz 3 \u00e7al\u0131\u015fma sayesine tespit edilen bu olumlu tablonun b\u00f6brek kanseri tedavisi i\u00e7in \u00f6nemli oldu\u011funu belirtti. Bir ba\u015fka immunoterapi kombinasyon \u00e7al\u0131\u015fmas\u0131nda g\u00f6re iki farkl\u0131 imm\u00fcno-onkolojik tedavi kombinasyonu ile ileri evre renal h\u00fccreli karsinom (RHK) hastalar\u0131n\u0131n yar\u0131s\u0131ndan fazlas\u0131n\u0131n 4 y\u0131l sonra da hayatlar\u0131n\u0131 s\u00fcrd\u00fcrd\u00fc\u011f\u00fc ortaya koyuldu.<\/p>\n
Her bilimsel \u00e7al\u0131\u015fman\u0131n b\u00f6brek kanseri tedavilerinin ba\u015far\u0131s\u0131nda \u00f6nemli rol \u00fcstlendi\u011fini ifade eden \u00dcr\u00fcn, \u201cKongrede payla\u015f\u0131lan bilimsel \u00e7al\u0131\u015fma sonu\u00e7lar\u0131 sayesinde metastatik renal h\u00fccreli karsinom tedavisinde \u00f6nemli \u00f6l\u00e7\u00fcde ilerlemeler oldu\u011funu g\u00f6rmek memnuniyet verici. Bulgular imm\u00fcnoterapi ve hedefe y\u00f6nelik bir ajan\u0131n ileri evre kanser hastalar\u0131n\u0131n sa\u011fkal\u0131m\u0131n\u0131 kayda de\u011fer \u00f6l\u00e7\u00fcde uzatma potansiyeline ve iki kat daha fazla progresyonsuz sa\u011fkal\u0131m faydas\u0131na sahip oldu\u011funa i\u015faret ediyor. Ayr\u0131ca sa\u011fl\u0131kla ili\u015fkili ya\u015fam kalitesindeki art\u0131\u015f da g\u00f6z \u00f6n\u00fcnde bulundurdu\u011fumuzda imm\u00fcnoterapi ve hedefe y\u00f6nelik bir ajan\u0131n birlikte kullan\u0131m\u0131na y\u00f6nelik ara\u015ft\u0131rmalar\u0131n\u0131n s\u00fcrd\u00fcr\u00fclmesinin b\u00f6brek kanseri tedavisindeki geli\u015fmelere b\u00fcy\u00fck katk\u0131 sa\u011flayaca\u011f\u0131n\u0131 s\u00f6yleyebiliriz\u201d dedi.<\/p>\n","protected":false},"excerpt":{"rendered":"
ANKARA \u00dcN\u0130VERS\u0130TES\u0130 TIBB\u0130 ONKOLOJ\u0130 B\u0130L\u0130M DALI \u00d6\u011eRET\u0130M \u00dcYES\u0130 DO\u00c7. DR. Y\u00dcKSEL \u00dcR\u00dcN KONGREDE B\u00d6BREK KANSER\u0130 TEDAV\u0130S\u0130NE Y\u00d6NEL\u0130K PAYLA\u015eILAN G\u00dcNCEL SONU\u00c7LARIN HEYECAN VER\u0130C\u0130 OLDU\u011eUNU D\u0130LE GET\u0130RD\u0130.<\/p>\n","protected":false},"author":1,"featured_media":1536374,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14,20],"tags":[2153,118060,13999,12864],"class_list":["post-1536373","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik","category-turkiye","tag-bobrek","tag-immunoterapilerin","tag-kanserinde","tag-onemi"],"_links":{"self":[{"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/posts\/1536373","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1536373"}],"version-history":[{"count":0,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/posts\/1536373\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/media\/1536374"}],"wp:attachment":[{"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1536373"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1536373"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1536373"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}